Product of the month

New perspectives for colorectal cancer screening

Innovative endoscopy system improves adenoma detection. Endoscopes are thin flexible tubes with imaging capabilities that doctors use to view the upper and lower GI tracts of their patients. The Fuse system uses three small cameras at the tip of a flexible GI endoscope, as compared with one at the tip of a standard, forward-viewing endoscope. With a wider 330° view, physicians see nearly twice the surface area and anatomy of the colon, including behind and into folds. A recent clinical study found that up to 41% of potentially pre-cancerous polyps hide and go undetected with the limited 170° view of standard, forward-viewing endoscopes

The Fuse® Full Spectrum Endoscopy System from EndoChoice provides GI...
The Fuse® Full Spectrum Endoscopy System from EndoChoice provides GI caregivers with a 330° Field of View + 4K Ultra HD Viewing Experience.
Source: EndoChoice
An international multi-center 185-patient tandem study reported in the Lancet...
An international multi-center 185-patient tandem study reported in the Lancet Oncology showed compelling results.
Source: EndoChoice

Fuse® Full Spectrum Endoscopy

For many years, colonoscopy has been the gold standard in colorectal cancer screening and diagnosis. Through careful examination with the endoscope, the physician is able to identify and detect precancerous polyps or growths that could be precursors to colorectal cancer.
•    Since the late 1980s, there have been no major innovations in flexible endoscopes
•    As a result, clinicians are limited by traditional endoscopes and can potentially miss key abnormalities

Fuse is a dramatic leap forward in endoscope technology and empowers physicians to provide a higher level of patient care.
•    Fuse is revolutionizing endoscopy by providing a 330° panoramic field of view during colonoscopy and a 245° field of view during upper endoscopy as compared to traditional endoscopes (no more than 170° for colonoscopes or up to 150° for gastroscopes)
•    Physicians see 94% more anatomy at a time with Fuse by providing a near panoramic field of view as compared to traditional colonoscopes
•    Fuse attracts and retains more patients

Advancing your GI practice

The Fuse endoscope provides to the clinician a panoramic, 330° field of view (1C colonoscope) and 245° (1G gastroscope), nearly twice that of the competing endoscopes, while maintaining all standard features, functions and feel.

A multi-center 185-patient tandem study reported in the Lancet Oncology* showed compelling results. 88 patients were randomly assigned to receive traditional forward-viewing colonoscopy first, and 97 to receive full-spectrum colonoscopy first.

By per-lesion analysis, the adenoma miss rate was significantly lower in patients in the full-spectrum endoscopy group than in those in the traditional forward-viewing colonoscopy group.

The latest advancement in the Fuse Full Spectrum Endoscopy portfolio is the innovative C38s, the world’s first endoscope with wide angle of view, slim profile, and large 3.8mm working channel. EndoChoice is the only company in the world to provide this combination of features.

* Gralnek et al. The Lancet Oncology, 2014


About EndoChoice
EndoChoice is a medtech company focused on the R&D, manufacturing and commercialization of platform technologies including endoscopic imaging, devices and infection control for specialists treating a wide range of gastrointestinal (GI) diseases.
•    Founded in 2008
•    Headquarters near Atlanta, Georgia, USA
•    International headquarters in the Hamburg, Germany area handling international sales, marketing, customer service, scope service and the worldwide manufacturing of Fuse® endoscopes
•    Active in more than 25 countries, with more than 2,500 customers in the U.S. alone

EndoChoice has rapidly developed a proprietary product portfolio, which includes the revolutionary Full Spectrum Endoscopy System (Fuse®). The Fuse system is comprised of colonoscopes and gastroscopes with multiple imagers so doctors can see more of the GI tract for diagnosis and treatment.

To learn more, visit


Read all latest stories

Related articles


Oncology early detection tool

Blood test for 50+ types of cancer promising for screening

Final results from a study of a blood test that can detect more than 50 types of cancer have shown that it is accurate enough to be rolled out as a multi-cancer screening test among people at higher…



Capsule cameras to test for cancer and diseases

Miniature cameras which patients can swallow to get checked for cancer are being trialled across the NHS. The imaging technology, in a capsule no bigger than a pill, can provide a diagnosis within…



This new, cheaper endoscope could redefine cancer screening

Engineers have developed a prototype endoscope which they say could cut the cost of manufacture from £80,000 to just £40. The redesigned device has the potential to revolutionise cancer screening…

Related products

Creative Biosciences - Colosafe

Creative Biosciences - Colosafe

Creative Biosciences (Guangzhou) Co., Ltd.
Therapixel · MammoScreen

Artificial Intelligence

Therapixel · MammoScreen

Subscribe to Newsletter